Anuj V. Peddada
Papers
4
Total Citations
62
H-Index
4
About
Anuj V. Peddada is a radiation oncologist whose research has made meaningful contributions to the field of genitourinary oncology, with a particular focus on stereotactic body radiation therapy (SBRT) for prostate and renal cancers. His work centers on optimizing treatment efficacy while carefully characterizing patient-reported quality of life outcomes, bridging the gap between cutting-edge radiotherapy techniques and real-world clinical practice. Peddada has been a key contributor to a landmark multi-institutional SBRT trial enrolling 259 low- and intermediate-risk prostate cancer patients across community and academic centers, producing influential outcome data at 5-year and 10-year follow-up milestones. His secondary analysis identifying predictors of genitourinary and bowel toxicity—his most-cited work with 25 citations—has direct implications for patient counseling and treatment planning. He has also advanced the evidence base for nephron-sparing radiosurgical treatment of primary renal cell carcinoma, demonstrating promising efficacy in patients who are surgical candidates or refuse surgery. Through collaborative multi-institutional research, Peddada has helped establish SBRT as a mature, community-deliverable treatment modality, contributing data that inform clinical guidelines and expand patient access to high-dose, hypofractionated radiotherapy approaches.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4